切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Ca2 -ATPases - HCV Proteases - Deubiquitinating enzymes (DUBs) - Vitamin D receptors (VDRs)

14件产品中的 1-10

页面
每页
清除全部
  1. Spautin-1
    B5873 Spautin-1
     1 Citation
    Target: Deubiquitinating enzymes (DUBs)|Autophagy
    Summary: 自噬抑制剂
      ≥13.5 mg/mL
      insoluble in H2O
  2. Thapsigargin
    B6614 Thapsigargin
     1 Citation
    中文名: 毒胡萝卜素
    Target: Ca2 -ATPases
    Summary: 肌质网状Ca2+-ATP酶抑制剂
      ≥39.2 mg/mL
      ≥4.12 mg/mL
  3. Calcifediol
    B2140 Calcifediol
    中文名: 骨化二醇
    Target: Vitamin D receptors (VDRs)
    Summary: 维生素D3的主要循环形式
      ≥13.65 mg/mL
      insoluble in H2O
  4. Doxercalciferol
    B2091 Doxercalciferol
     1 Citation
    中文名: 度骨化醇
    Target: Vitamin D receptors (VDRs)
    Summary: 维生素D受体激活剂
      ≥11.5 mg/mL
      insoluble in H2O
  5. ML-323
    B1317 ML-323
    Target: Deubiquitinating enzymes (DUBs)
    Summary: USP1-UAF1抑制剂
      ≥15.05 mg/mL
      ≥2.25 mg/mL
  6. Lithocholic Acid
    A8463 Lithocholic Acid
    中文名: 石胆酸
    Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)
    Summary: 维生素D受体PXR和FXR的激活剂
      ≥12.95 mg/mL
      insoluble in H2O
  7. Daclatasvir (BMS-790052)
    A5618 Daclatasvir (BMS-790052)
    中文名: 达卡他韦
    Target: HCV Proteases
    Summary: HCV NS5A抑制剂
      ≥36.6 mg/mL
      insoluble in H2O
  8. PR-619
    A8212 PR-619
    Target: Deubiquitinating enzymes (DUBs)
    Summary: 去泛素化酶(DUBs)抑制剂
      ≥11.15 mg/mL
      insoluble in H2O
  9. NSC 687852 (b-AP15)
    A4453 NSC 687852 (b-AP15)
    Target: Deubiquitinating enzymes (DUBs)
    Summary: 19S调节颗粒抑制剂
      ≥20.95 mg/mL
      insoluble in H2O
  10. Vialinin A
    A4429 Vialinin A
    Target: Deubiquitinating enzymes (DUBs)|IL Receptors|CCL2
    Summary: USP/IsoT/UCH-L1 DUB抑制剂
      Soluble in DMSO

14件产品中的 1-10

页面
每页